Dogwood Therapeutics Inc
DWTX
NASDAQ
Biotechnology
$2.15
USD
+0.17 (+8.59%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $66.59M
Volume 105.8K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-28.32M
TTM
— YoY
Operating Cash Flow
$-15.52M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 2.0 | 1.4 | 1.3 | 1.5 | 2.4 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 4.4 | 3.9 | 15.8 | 3.8 | 5.1 |
Operating Income | -4.4 | -3.9 | -15.8 | -3.8 | -5.1 |
EBITDA | -4.4 | -3.9 | -15.8 | -3.8 | -5.1 |
Other Income / Expense | -6.2 | 0.0 | -0.0 | 0.0 | 0.0 |
Total Other Income / Expense | -6.3 | 0.1 | 0.1 | 0.1 | 0.1 |
Income Before Income Taxes | -10.7 | -3.8 | -15.7 | -3.7 | -5.0 |
Income Taxes | 0.2 | 0.0 | -0.0 | 0.0 | 0.0 |
Net Income | -10.9 | -3.8 | -15.7 | -3.8 | -5.0 |
Consolidated Net Income / Loss | -10.9 | -3.8 | -15.7 | -3.8 | -5.0 |
Net Income Attributable to Common Shareholders | -12.2 | -3.8 | -15.7 | -3.8 | -5.0 |
Basic EPS | -$8.45 | -$1.99 | -$8.20 | -$0.26 | -$0.15 |
Diluted EPS | -$8.45 | -$1.99 | -$8.20 | -$0.26 | -$0.15 |
Basic Shares Outstanding | 1.4M | 1.9M | 1.9M | 14.6M | 33.5M |
Diluted Shares Outstanding | 1.4M | 1.9M | 1.9M | 14.6M | 33.5M |